SEC Form 3 · accession 0001104659-18-045598
Rubius Therapeutics, Inc. · RUBY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Torben Straight Nissen
Officer — President
Period of report
Jul 17, 2018
Accepted (ET)
Jul 17, 2018 · 8:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001709401
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 1,860,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.18 | holding | — | — | — | — | Nov 28, 2026 | Common Stock | 350,000 | — | D |
| Stock Option (Right to Buy)F1 | $0.19 | holding | — | — | — | — | Apr 2, 2027 | Common Stock | 115,000 | — | D |
| Stock Option (Right to Buy)F2 | $4.74 | holding | — | — | — | — | Feb 14, 2028 | Common Stock | 333,500 | — | D |
Explanation of responses
- F150% of this option shall vest upon the achievement of a performance milestone; 25% of this option shall vest upon the first anniversary of achievement of a second performance milestone; and 12.5% of this option shall vest upon each of the second and third anniversaries of achievement of such second performance milestone.
- F225% of this option shall vest on January 31, 2019, then in 36 equal monthly installments thereafter.
Remarks
Exhibit 24 - Power of Attorney